CAS: 2145109-70-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Praluzatamab REF: TM-T77122CAS: 2145109-70-0 | SDS-PAGE:95% SEC-HPLC:99.99% | 305.00 €~1,290.00 € | Wed 04 Dec 24 |
 | Praluzatamab REF: 3D-CLA1604CAS: 2145109-70-0 | - - - | To inquire | Mon 16 Dec 24 |
Praluzatamab
CAS:2145109-70-0
Praluzatamab, a monoclonal antibody, targets ALCAM/CD116 for potential breast cancer studies.
Purity:
SDS-PAGE:95% SEC-HPLC:99.99%
Color and Shape:
Liquid
Molecular weight:
146.9 kDa
Ref: TM-T77122
| 1mg | 305.00 € | ||
| 5mg | 810.00 € | ||
| 10mg | 1,290.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Praluzatamab
CAS:2145109-70-0
Anti-activated leukocyte cell adhesion mlecule (ALCAM/CD116) monoclonal antibody
Ref: 3D-CLA1604
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
